Dr. Acklin-Wehnert is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
20 Duke Medicine Circle
Durham, NC 27710
Education & Training
Duke University HospitalResidency, Radiation Oncology, 2021 - 2025
University of Arkansas For Medical Sciences College of MedicineClass of 2020- University of Arkansas for Medical Sciences (UAMS) College of MedicineInternship, Transitional Year
Publications & Presentations
PubMed
- Neoadjuvant Short- Vs. Long-Course Radiation for Locally Advanced Rectal Cancer: How to Choose.Christopher G Willett, Scarlett Acklin-Wehnert
Current Treatment Options in Oncology. 2024-04-01 - Toxicity and Outcomes of Moderately Hypofractionated Radiation for Prostate Cancer With Seminal Vesicle Involvement.Scarlett Acklin-Wehnert, David Carpenter, Divya Natesan, R Warren Floyd, Laura Waters
Advances in Radiation Oncology. 2023-04-24 - 4 citationsNicotinamide riboside alleviates cisplatin-induced peripheral neuropathy via SIRT2 activation.Scarlett Acklin, Ratan Sadhukhan, Wuying Du, Mousumi Patra, Ravi Cholia
Neuro-Oncology Advances. 2022-06-27
Journal Articles
- SIRT2 Protects Peripheral Neurons From Cisplatin-Induced Injury by Enhancing Nucleotide Excision RepairManchao Zhang*, Wuying Du*, Scarlett Acklin*, Shengkai Jin, Fen Xia, Journal of Clinical Investigation, 5/4/2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
